Advertisement
Screener

AMERICAN SHARED HOSPITAL SERVICES (AMS) Overview

AMERICAN SHARED HOSPITAL SERVICES (AMS) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.07; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.09; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.00; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.04; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$1.22$1.48$1.78$2.14$2.58$3.112025-09-292026-09-29$1.22$1.54$1.94$2.44$3.08$3.872021-09-292026-09-29$1.21$1.60$2.13$2.83$3.76$4.992016-09-292026-09-29$0.95$1.43$2.14$3.21$4.83$7.252006-09-292026-09-29$0.18$0.42$0.98$2.28$5.30$12.341984-07-032026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$1.44
Previous close
$1.43
Change
$0.01
Change (%)
0.70%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

AMS
-31.77%
S&P 500
(m)

1 year

AMS
-51.22%
S&P 500
(m)

3 years

AMS
-41.65%
S&P 500
(m)

5 years

AMS
-47.40%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.07

-0.18-0.090.000.090.1831 Mar 2025: estimate (m); actual -0.1031 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.0430 Jun 2025(m)30 Sept 2025: estimate (m); actual 0.0030 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.0931 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.0730 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.07(m)(m)
1 Jan 202631 Mar 2026(m)-0.09(m)(m)
1 Jul 202530 Sept 2025(m)0.00(m)(m)
1 Apr 202530 Jun 2025(m)-0.04(m)(m)
1 Jan 202531 Mar 2025(m)-0.10(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -0.23

-0.31-0.100.100.300.5131 Dec 2021: estimate (m); actual 0.0331 Dec 2021(m)31 Dec 2022: estimate (m); actual 0.2131 Dec 2022(m)31 Dec 2023: estimate (m); actual 0.1031 Dec 2023(m)31 Dec 2024: estimate (m); actual 0.3331 Dec 2024(m)31 Dec 2025: estimate (m); actual -0.2331 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-0.23(m)(m)
1 Jan 202431 Dec 2024(m)0.33(m)(m)
1 Jan 202331 Dec 2023(m)0.10(m)(m)
1 Jan 202231 Dec 2022(m)0.21(m)(m)
1 Jan 202131 Dec 2021(m)0.03(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 8.43M ■ Earnings -0.51M — Profit margin -6.10%

-1.72M-9.6%2.03M-6.2%5.77M-2.7%9.52M0.8%30 Sept 2025: revenue 7.17M; earnings -0.02M; profit margin -0.24%30 Sept 202531 Dec 2025: revenue 7.73M*; earnings -0.63M*; profit margin -8.17%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 7.08M; earnings -0.61M; profit margin -8.64%31 Mar 202630 Jun 2026: revenue 8.43M; earnings -0.51M; profit margin -6.10%30 Jun 2026

31 Dec 2025 ■ Revenue 28.08M ■ Earnings -1.55M — Profit margin -5.53%

-5.14M-6.5%7.22M-1.4%19.57M3.6%31.93M8.7%31 Dec 2022: revenue 19.75M; earnings 1.33M; profit margin 6.73%31 Dec 202231 Dec 2023: revenue 21.32M; earnings 0.61M; profit margin 2.86%31 Dec 202331 Dec 2024: revenue 28.34M; earnings 2.19M; profit margin 7.71%31 Dec 202431 Dec 2025: revenue 28.08M; earnings -1.55M; profit margin -5.53%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$1.44(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$1.44High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning AMS

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-1.77M
Profit margin
-5.83%
Return on assets · 12 month
-3.06%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
8.73K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-2.04%*
Total return · month
-2.04%*
Total return · quarter
-11.47%*
Total return · half year
-20.40%*
Total return · year to date
-31.77%*
Total return · 1 year
-51.22%*
Total return · 3 years
-41.65%*
Total return · 5 years
-47.40%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$30.41M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

AMERICAN SHARED HOSPITAL SERVICES Overview

View more →

(m)

(m)

SEC CIK
744825
Industry (SIC)
8071 Services-Medical Laboratories
Country of operation
United States
Business address
601 MONTGOMERY STREET, SUITE 1112, SAN FRANCISCO, California, 94111, United States
Fiscal year end
1231
Phone
415-788-5300

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45